Trial Site Detail

 

Drug:
QINLOCK Ripretinib DCC-2618
Trial:
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Huntsman Cancer Institute

2000 Circle of Hope     
Salt Lake City , UT 84103
USA

 

Principal Investigator:
Howard Colman
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Huntsman Cancer Institute Website:
http://oncore-app1.hci.utah.edu/sip-mobile/flowchart.html

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.